Herbalife tangle shows how twisted the stock game is

Public announcements by large shareholders send share price zooming or plummeting; not illegal, but should it be?

Feb 25, 2013 @ 10:27 am

By William D. Cohan

What are we to make of the ability of hedge-fund managers and other influential investors to manipulate the market with impunity and make millions of dollars doing it?

The question was raised anew on Feb. 16 after news broke that Daniel Loeb of Third Point LLC had sold a portion of his 8.9 million shares in Herbalife Ltd. (HLF) Loeb's action, while perfectly legal under current law, deserves a thorough review by the Securities and Exchange Commission -- which is supposed to protect small investors in the capital markets -- and its next likely chairman, Mary Jo White.

Loeb, of course, is one of the brilliant young (and not-so- young) investors who have squared off against one another in the battle over Herbalife, the purveyor of weight-loss and other nutritional products through a network of independent distributors. Loeb came in on the long side of the fight, along with billionaire Carl Icahn, who announced on Valentine's Day that he owns almost 13 percent of Herbalife's existing shares. They are squared off against Bill Ackman, whose Pershing Square Capital Management LP announced on Dec. 20 that it had amassed a $1 billion short position in Herbalife, which Ackman called an illegal pyramid scheme.

Every time one of these respected hedge-fund managers or takeover kings goes on cable TV and explains his latest thinking or actions -- a growing addiction, it seems -- Herbalife's stock jumps or dives like a trained seal.

Stock's Rise

That was especially true on Feb. 15, the day after Icahn announced in a filing with the SEC that he had amassed more than 14 million Herbalife shares and intended to meet with the company's management to discuss “business and strategic alternatives to enhance shareholder value, such as a recapitalization or a going-private transaction.” The stock soared 20 percent on the news in after-hours trading on Feb. 14, according to CNBC.

The other shoe dropped Feb. 16, when “sources” confirmed to CNBC and the New York Post that Loeb had sold a portion of the Herbalife stock he owned into the Icahn-ignited rally. (Third Point eventually confirmed the sale.)

The problem with that, in my mind, arises from Loeb's own much-heralded Jan. 9 announcement -- in a filing with the SEC and in a letter to his investors -- that he had acquired 8.9 million Herbalife shares, or 8.24 percent of the market. It was a response, he said, to the “panicked selling” that followed Ackman's Dec. 20 announcement of his short position, which drove Herbalife stock into the mid-$20 per share.

In his letter to his Third Point investors, Loeb described the company's robust financial performance, including earnings per share that had increased “approximately 20-50 percent each year since 2004,” noting that “this type of steady non- cyclical growth is hard to find.” He rejected Ackman's claim that Herbalife “exploited and harmed” its “loyal customer and distributor base” and its products were “commodities sold at inflated prices” and not supported by sufficient advertising or research and development.

Rather, Loeb wrote, the stock could easily return to its April 2012 price of about $70 per share (it was then at about $39). At a minimum, he wrote, the stock should be valued at $55 to $68 per share, offering Third Point “40-70% upside from here and making the company a compelling long investment.” Over the next few days, the Herbalife stock rose 10 percent.

Taking Advantage

What I question is whether, after making a huge public commotion about buying the Herbalife stock as a “compelling long investment,” it is then ethical to sell a big chunk of that stock at a price far below what you told investors it was really worth. Should it even be legal? Isn't this just taking unfair advantage of your ability to move markets?

Securities laws exist to prevent “market manipulation” of the “pump and dump” variety, whereby an investor publicly announces a large stake in a company, the market moves up on the announcement, and then the investor sells the position, or a portion of it after the market moves.

“These activist investors must be careful NOT to cross the line of creating a pump and dump, which is illegal,” Ken Luskin, the president of Intrinsic Value Asset Management Inc. in Santa Monica, California, wrote in an e-mail to me after my recent column about hedge-fund investor David Einhorn's public comments on Apple Inc. “So, if these activists do quickly sell/close out their position after talking up the merits, they could be accused of 'market manipulation.'”

No doubt Third Point would hotly dispute that it manipulated the market, especially because Loeb still owns some Herbalife stock -- although he won't say how much -- and is free to increase or decrease his stake in the future. I can easily imagine him saying that his decision to sell some of his Herbalife stock is evidence that he's not locked into a zealous viewpoint and is simply trying to make money for his investors, and that there is no worry on his end that the SEC might consider his behavior a violation of pump and dump laws.

And that, to me, is a problem. Because the only people who end up losing in situations like this are the very ones the SEC is supposed to be protecting -- the little guys.

--Bloomberg News--

(William D. Cohan, the author of “Money and Power: How Goldman Sachs Came to Rule the World,” is a Bloomberg View columnist. He was formerly an investment banker at Lazard Freres, Merrill Lynch and JPMorgan Chase. The opinions expressed are his own.)


What do you think?

View comments

Recommended for you

Upcoming Event

Mar 13



InvestmentNews is honoring female financial advisers and industry executives who are distinguished leaders at their firms. These women have advanced the business of providing advice through their passion, creativity, inclusive approach and... Learn more

Featured video


Why integration is essential (and how it works)

Integration has been one of the biggest fintech themes in 2017. But why (and how) does this work? Matt Brown of CAIS and Sean Mullen of Advice Period explain.

Video Spotlight

Help Clients Be Prepared, Not Surprised

Sponsored by Prudential

Recommended Video

Path to growth

Latest news & opinion

One adviser's story of losing his son to the opioid epidemic

John W. Brower, president and CEO of JW Brower & Associates, shares the story behind his son's death from a heroin overdose and how it inspired him to help others break the cycle of addiction.

Tax reform will boost food, chemicals, rail stocks. Technology? Not so much

Conagra and Berkshire Hathaway are two stocks that should benefit most from changes in the tax code.

Brace for steepest rate hikes since 2006 in new year

Citigroup, JPMorgan Chase predict average interest rates across advanced economies will climb to at least 1 percent in 2018.

Why private equity wants a piece of the RIA market

Several factors, including consolidation in the independent advice industry and PE's own growing mountain of cash, are fueling the zeal to invest.

Finra bars former UBS rep for private securities transactions

Regulator says Kenneth Tyrrell engaged in undisclosed trades worth $13 million.


Subscribe and Save 60%

Premium Access
Print + Digital

Learn more
Subscribe to Print